Solón Javier Garcés Eisele

Dr. Solón Javier Garcés Eisele

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Hematology/Oncology and Stem Cell Therapy
Verified
Journal Article
Open access
NLNancy Labastida-Mercado
Nancy Labastida-Mercado
SGSamantha Galindo-Becerra
Samantha Galindo-Becerra
SESolón Javier Garcés Eisele
Solón Javier Garcés Eisele
PCPerla Colunga-Pedraza
Perla Colunga-Pedraza
VGValeria Guzman-Olvera
Valeria Guzman-Olvera
GRGuillermo José Ruiz-Argüelles
Guillermo José Ruiz-Argüelles
CONTEXT AND OBJECTIVE: By using molecular markers, it is possible to gain information on both the classification and etiopathogenesis of chronic myeloproliferative neoplasias (MPN). METHODS: In a group of 27 Mexican mestizo patients with MPNs, we studied seven molecular markers: the BCR/ABL1 fusion gene, the JAK2 V617F mutation, the JAK2 exon 12 mutations, the MPL W515L mutation, the MPL W515K mutation, and the calreticulin (CALR) exon 9 deletion or insertion. Patients with the BCR/ ABL1 fusion gene were excluded. We studied 14 patients with essential thrombocythemia (ET), eight with polycythemia vera (PV), four with primary myelofibrosis (MF), and one with undifferentiated MPN. RESULTS: We found twelve individuals with the JAK2 V617F mutation; five of them had been clinically classified as PV, five as ET, and one as MF. One patient with the MPL W515L was identified with a clinical picture of ET. Five patients with the CALR mutation were identified, four ET and one MF. No individuals with either the MPL W515K mutation or the JAK2 exon 12 mutations were identified. The most consistent relationship was that between PV and the JAK2 V617F mutation ( p = .01). CONCLUSIONS: Despite its small size, the study shows much less prevalence of JAK2 mutation in PV, ET and MF, which does not match international data.

29 March 2025 in Sclerosis
Verified
Journal Article
Open access
PDF file
MGMoisés Manuel Gallardo-Pérez
Moisés Manuel Gallardo-Pérez
ARAlejandro Ruiz-Argüelles
Alejandro Ruiz-Argüelles
GRGuillermo José Ruiz-Argüelles
Guillermo José Ruiz-Argüelles
VRVirginia Reyes-Núñez
Virginia Reyes-Núñez
SSSilvia Soto-Olvera
Silvia Soto-Olvera
SESolón Javier Garcés Eisele
Solón Javier Garcés Eisele
Introduction: Approximately 80% of individuals with multiple sclerosis (MS) have a positive response to autologous hematopoietic stem cell transplantation (aHSCT). Markers that may predict the transplant outcome are necessary. The objective of this work is to identify markers that may refine the selection of patients with multiple sclerosis who could benefit from aHSCT. Methods: We evaluated the levels of six biomarkers in the peripheral blood of patients with MS before aHSCT. The design of this study is cross-sectional; patients were divided into two transplant-responses-at-12-months groups, responders (ΔEDSS < 0) and non-responders (ΔEDSS > 0). Pre-transplant samples were used to assess the different markers. Results: Thirty-four patients were enrolled: fourteen were non-responders and twenty were responders to aHSCT. Among the evaluated biomarkers, a significant difference was only detected in miR-146a levels, with increased values in the non-responder group. Conclusions: The biomarker miR146a could be useful to evaluate the response to aHSCT in patients with MS.

27 August 2026 in Molecules
Verified
Journal Article
Open access
PDF file
RCRubi Esmeralda González Campos
Rubi Esmeralda González Campos
EBElizabeth Bautista-Rodríguez
Elizabeth Bautista-Rodríguez
CACésar Emmanuel Ale
César Emmanuel Ale
SESolón Javier Garcés Eisele
Solón Javier Garcés Eisele
LHLuis Ricardo Hernández
Luis Ricardo Hernández
ZJZaida Nelly Juárez
Zaida Nelly Juárez
Tradescantia pendula is a medicinal plant traditionally used in Mexico to treat inflammatory and infectious conditions. This study evaluated the phytochemical composition, antimicrobial activity, toxicity, and cytotoxicity of T. pendula extracts. Plant material was sequentially extracted using hexane, chloroform, and methanol, followed by phytochemical screening, antimicrobial evaluation against clinically relevant bacterial strains, toxicity assessment using the Artemia salina model, cytotoxicity analysis in HaCaT and U937 cell lines, and GC–MS characterization. Phytochemical screening of the chloroform extract revealed the presence of flavonoids, tannins, triterpenes, and glycosides. Antimicrobial activity was observed mainly against Escherichia coli and Pseudomonas aeruginosa, with bacterial viability reduced by up to 95.2%. Toxicity assays in Artemia salina demonstrated marked biological activity, with LC50 values of 63.54, 23.12, and 23.05 μg/mL for the hexane, chloroform, and methanol extracts, respectively. Cytotoxicity assays revealed cell type-dependent responses, with U937 monocytic cells exhibiting greater sensitivity than HaCaT keratinocytes. All three extracts produced non-monotonic concentration–response profiles, with enhanced metabolic activity at intermediate concentrations and substantial decreases in cell viability at lower concentrations. GC–MS analysis revealed lipophilic metabolites, including phytol-related compounds and fatty acid esters. These findings suggest that T. pendula is a promising source of bioactive metabolites with antimicrobial and cytotoxic properties, supporting its ethnopharmacological relevance and potential pharmacological applications.